Merit Medical Systems (MMSI) Raw Materials (2015 - 2026)

Merit Medical Systems has disclosed Raw Materials across 11 years of filings, most recently posting $114.6 million for Q1 2026.

• Raw Materials for Q1 2026 came in at $114.6 million, down 3.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.6 million (down 3.26% YoY), and the FY2025 annual result was $110.7 million, changed 0.17% from the prior year.
• Raw Materials came in at $114.6 million for Q1 2026 at Merit Medical Systems, up from $110.7 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $119.6 million in Q4 2023 to a low of $68.4 million in Q1 2022.
• The 5-year median for Raw Materials is $113.2 million (2024), against an average of $105.0 million.
• Across the five-year window, Raw Materials soared 52.23% in 2023 and declined 7.57% in 2024, its largest moves.
• Merit Medical Systems' Raw Materials stood at $89.4 million in 2022, then jumped by 33.72% to $119.6 million in 2023, then dropped by 7.57% to $110.5 million in 2024, then climbed by 0.17% to $110.7 million in 2025, then rose by 3.48% to $114.6 million in 2026.
• The last three Raw Materials figures came in at $114.6 million (Q1 2026), $110.7 million (Q4 2025), and $113.5 million (Q3 2025), per Business Quant data.